BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18162220)

  • 1. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.
    Cairo MS; Rocha V; Gluckman E; Hale G; Wagner J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):44-53. PubMed ID: 18162220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
    Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?
    Hough R; Cooper N; Veys P
    Br J Haematol; 2009 Dec; 147(5):593-613. PubMed ID: 19709086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
    Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
    Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for alternative hematopoietic stem cell donors for pediatric patients.
    Rocha V; Locatelli F
    Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.
    Goussetis E; Peristeri I; Kitra V; Papassavas AC; Theodosaki M; Petrakou E; Spiropoulos A; Paisiou A; Soldatou A; Stavropoulos-Giokas C; Graphakos S
    Blood Cells Mol Dis; 2011 Feb; 46(2):177-81. PubMed ID: 21095146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative donor transplants for high-risk acute myeloid leukemia.
    Gupta V
    Curr Opin Hematol; 2008 Mar; 15(2):115-20. PubMed ID: 18300757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplant outcomes in acute leukemia. II.
    Hough R; Rocha V
    Semin Hematol; 2010 Jan; 47(1):51-8. PubMed ID: 20109612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a best graft source of transplantation in acute myeloid leukemia?
    Ballen KK
    Best Pract Res Clin Haematol; 2015; 28(2-3):147-54. PubMed ID: 26590772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.
    Marks DI; Aversa F; Lazarus HM
    Bone Marrow Transplant; 2006 Oct; 38(7):467-75. PubMed ID: 16892073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing role of stem cell transplantation in childhood.
    Locatelli F; Giorgiani G; Di-Cesare-Merlone A; Merli P; Sparta V; Moretta F
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S3-7. PubMed ID: 18545240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies.
    Krishnamurti L; Abel S; Maiers M; Flesch S
    Bone Marrow Transplant; 2003 Apr; 31(7):547-50. PubMed ID: 12692619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies of the donor search for children with second CR ALL lacking a matched sibling donor.
    Lanino E; Sacchi N; Peters C; Giardino S; Rocha V; Dini G; ;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S75-9. PubMed ID: 18545249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord blood immunology and stem cell transplantation.
    Bradley MB; Cairo MS
    Hum Immunol; 2005 May; 66(5):431-46. PubMed ID: 15935881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.
    Macmillan ML; Blazar BR; DeFor TE; Wagner JE
    Bone Marrow Transplant; 2009 Mar; 43(6):447-54. PubMed ID: 18955980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
    Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Falkenburg JH; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M;
    Bone Marrow Transplant; 2015 Apr; 50(4):476-82. PubMed ID: 25642761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of cord blood for stem cell transplantation.
    Vanichsetakul P
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S93-100. PubMed ID: 17718293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative donor transplantation in acute myeloid leukemia: which source and when?
    Zuckerman T; Rowe JM
    Curr Opin Hematol; 2007 Mar; 14(2):152-61. PubMed ID: 17255793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The great debate: haploidentical or cord blood transplant.
    Ballen KK; Spitzer TR
    Bone Marrow Transplant; 2011 Mar; 46(3):323-9. PubMed ID: 21042314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.